146 results on '"Fernández-Peñas, Pablo"'
Search Results
2. The impact of skin cancer prevention efforts in New South Wales, Australia: Generational trends in melanoma incidence and mortality
3. Impact of a Patient Support Program on time to discontinuation of adalimumab in Australian adult patients with immune-mediated inflammatory diseases–an observational study.
4. Drug survival of biologics in psoriasis: An Australian multicentre retrospective study.
5. Baricitinib Rapidly Improves Skin Pain Resulting in Improved Quality of Life for Patients with Atopic Dermatitis: Analyses from BREEZE-AD1, 2, and 7
6. Prevalence of skin examination behaviours among Australians over time
7. Investigating proteome changes between primary and metastatic cutaneous squamous cell carcinoma using SWATH mass spectrometry
8. Proteomics: An emerging approach for the diagnosis and classification of cutaneous squamous cell carcinoma and its precursors
9. Data Independent Acquisition Proteomic Analysis Can Discriminate between Actinic Keratosis, Bowen’s Disease, and Cutaneous Squamous Cell Carcinoma
10. ¿Cuánta carga asistencial suponen las dermatosis pediátricas en la actividad ambulatoria en la dermatología española? Resultados del muestreo aleatorio nacional DIADERM
11. ACEMID cohort study: protocol of a prospective cohort study using 3D total body photography for melanoma imaging and diagnosis
12. Differential proteomic analysis of actinic keratosis, Bowen’s disease and cutaneous squamous cell carcinoma by label-free LC–MS/MS
13. Allergic Contact Dermatitis of the Anogenital Region in Men and Women
14. Genomic and proteomic findings in early melanoma and opportunities for early diagnosis
15. Informing a position statement on the use of artificial intelligence in dermatology in Australia
16. Adverse Reactions to Biologics: Melanoma (Ipilimumab, Nivolumab, Pembrolizumab)
17. Incidence of Basal Cell Carcinoma and Squamous Cell Carcinoma in Patients on Antiprogrammed Cell Death-1 Therapy for Metastatic Melanoma
18. Assessing the value of precision medicine health technologies to detect and manage melanoma
19. 33259 Improvements in anxiety and depression among patients with moderate to severe plaque psoriasis treated with certolizumab pegol: Three-year results from 2 phase 3 trials (CIMPASI-1 and CIMPASI-2)
20. Atypical fibroxanthoma management: Recurrence, metastasis and disease‐specific death
21. Intracorneal pustular drug eruption, a novel cutaneous adverse event in anti-programmed cell death-1 patients that highlights the effect of anti-programmed cell death-1 in neutrophils
22. Melanocytic lesion evolution patterns with targeted therapies and immunotherapies for advanced metastatic melanoma: An observational study
23. Informing a position statement on the use of artificial intelligence in dermatology in Australia.
24. Genomic and proteomic findings in early melanoma and opportunities for early diagnosis.
25. Infectious eccrine hidradenitis: sweat glands as the portal of entry for cellulitis
26. The microbiome and atopic eczema: More than skin deep
27. 25997 Safety of tildrakizumab 100 mg and 200 mg through 5 years of exposure in reSURFACE 1
28. Specialised skin cancer spectral library for use in data‐independent mass spectrometry
29. A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention
30. Localized cutaneous immunoglobulin G4
31. Uncovering the unmet needs among psoriasis patients in the Asia‐Pacific region
32. 43927 The Impact of Treatment with Guselkumab on Skin-related Quality of Life in Male and Female Patients with Moderate to Severe Psoriasis: Results from the VOYAGE 1 and 2 Trials
33. Image analysis in advanced skin imaging technology
34. Dermatology Over the Rainbow
35. Diffuse melanosis cutis in the setting of BRAFV600E mutant melanoma and treatment with targeted therapies
36. Phototherapy for the treatment of cutaneous graft versus host disease
37. Quality of life in non-melanoma skin cancer
38. Neurocognitive Function and Quality of Life Outcomes in the ONTRAC Study for Skin Cancer Chemoprevention by Nicotinamide
39. Maintenance of skin clearance with ixekizumab treatment of psoriasis: Three-year results from the UNCOVER-3 study
40. 27043 Achieving and maintaining long-term optimal improvements in patient-reported symptoms, signs, and quality of life among patients with moderate-to-severe psoriasis treated with guselkumab: 5-year data from VOYAGE 1
41. Is it worthy to treat hidradenitis suppurativa with adalimumab in patients with melanoma and other debilitating systemic diseases? A series of clinical dilemmas
42. Sun Exposure Habits and Sun Protection Practices of Skaters.
43. Management of the cutaneous adverse effects of antimelanoma therapy
44. Atypical fibroxanthoma management: Recurrence, metastasis and disease-specific death
45. Systemic and erythrodermic reactions following repeated exposure to bites from the Common bed bug Cimex lectularius (Hemiptera: Cimicidae)
46. Classification of high risk basal cell carcinoma subtypes: experience of the ONTRAC study with proposed definitions and guidelines for pathological reporting
47. Direct Cost-Analysis of Mohs Micrographic Surgery and Traditional Excision for Basal Cell Carcinoma at Initial Margin Clearance
48. Sun Exposure Habits and Sun Protection Practices of Skaters
49. The microbiome and atopic eczema: More than skin deep
50. Intracorneal pustular drug eruption, a novel cutaneous adverse event in anti-programmed cell death-1 patients that highlights the effect of anti-programmed cell death-1 in neutrophils.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.